Resources

Arrowg+ard Blue Plus™ Protection Clinical References
Technology Overview Video
Request More Information
USA / Product Areas / Vascular Access / Central Access / Short-Term Central Venous Catheters (CVC)
Product Overview Benefits Features Kitting Options Order Information

Arrowg+ard Blue Plus™ CVC

Protected. Proven. Preferred.

The Arrowg+ard Blue Plus™ Central Venous Catheter (CVC) is the only broad-spectrum antimicrobial CVC designed to help reduce the risk of catheter-related complications.


At the core of the protection is Chlorhexidine—a proven, broad-spectrum antimicrobial. By disrupting the cell membrane of microbes, Chlorhexidine provides defense against a wide range of pathogens. This advanced protection is integrated directly into the catheter surface, protecting against microbial colonization and, subsequently, biofilm development.1


Proven to reduce CLABSIs by 70-100%.4-7


Chlorhexidine Antimicrobial Protection Offers:
  • Broad-Spectrum Protection against:
    • Gram-positive bacteria
    • Gram-negative bacteria
    • Fungi
  • Fast Acting
    Bacterial uptake typically within 20 seconds2
  • Complete Protection from Tip to Hub
    Chlorhexidine-based protection is integrated into both the internal and external surfaces of the catheter3

Contact Us to Learn More
View Our Product Catalog

  • With broader spectrum protection than antibiotics and a faster kill rate than other antimicrobials (e.g., povidone-iodine).2
  • Complete protection of the internal fluid pathway and external catheter surface.3

  • Arrowg+ard Blue Plus™ Protection is supported by 30+ clinical studies.14
  • Chlorhexidine kills organisms and protects against microbial colonization and, subsequently biofilm development1

  • Market-leading technology trusted by clinicians and widely adopted across ICUs, EDs, and ORs.8
  • Received the highest levels of recommendation by the CDC9, INS10, SHEA11 and APIC12.
  • Available in Arrow™ ErgoPack™ Complete Kits designed to support standardization, protocol alignment, and confidence at the bedside.

Product Features

Trusted by Clinicians.8 Supported by Guidelines.9-12

Proven to reduce CLABSIs by 70-100%.4-7

Staggered Exit Ports
Reduces the risk of mixing incompatible drugs and solutions that may precipitate
Pressure Injection
Information clearly marked on hubs for easy reference looping
Arrowg+ard Blue Plus™ Antimicrobial Protection
Labeling indicates Chlorhexidine-based antimicrobial protection on both the external and internal surfaces
10 mL/second
Maximum flow rate
Blue FlexTip™ Feature
Soft, contoured tip designed to minimize the risk of vessel trauma 15

Arrow™ ErgoPack™ Complete Kit

Each Arrow™ ErgoPack™ Complete Kit includes the components needed to support maximal barrier precautions—helping clinicians comply with evidence-based guidelines while improving efficiency and reducing procedural variability.9-12, 16


Order Information

Available in multiple configurations to make it easy to find the right kit to meet your needs.

Product

Description

CDC-42802-XPN1A

AGB+ CVC 2-L 8Fr x 16CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-42802-XPCN1A

AGB+ CVC 2-L 8Fr x 16CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing

CDC-45802-XPN1A

AGB+ CVC 2-L 8Fr x 20CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-45802-XPCN1A

AGB+ CVC 2-L 8Fr x 20CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing

CDC-42703-XPN1A

AGB+ CVC 3-L 7Fr x 16CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-42703-XPCN1A

AGB+ CVC 3-L 7Fr x 16CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing

CDC-45703-XPN1A

AGB+ CVC 3-L 7Fr x 20CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-45703-XPCN1A

AGB+ CVC 3-L 7Fr x 20CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing

CDC-42854-XPN1A

AGB+ CVC 4-L 8Fr x 16CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-42854-XPCN1A

AGB+ CVC 4-L 8Fr x 16CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing

CDC-45854-XPN1A

AGB+ CVC 4-L 8Fr x 20CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-45854-XPCN1A

AGB+ CVC 4-L 8Fr x 20CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing



Want to learn more or schedule a Arrowg+ard Blue Plus™ CVC demo/trial?

References:

  1. Mohammadi Z, Abbott PV. The properties and applications of chlorhexidine in endodontics. Int Endod J. 2009;42(4):288-302. doi:10.1111/j.1365-2591.2008.01540.x
  2. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147-179. doi:10.1128/CMR.12.1.147
  3. https://www.accessdata.fda.gov/cdrh_docs/pdf/K993691.pdf
  4. Rosenthal VD, Yin R, Jin Z, et al. Multicenter, Multinational, Prospective Cohort Study of the Impact of Chlorhexidine Impregnated vs. Plain Central Lines on Central Line-associated Bloodstream Infections. Am J Infect Control. 2025;53(8):862-868. doi:https://doi.org/10.1016/j.ajic.2025.03.002
  5. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. Am J Infect Control. 2014;42(3):321-324. doi:10.1016/j.ajic.2013.09.022
  6. Lorente L, Lecuona M, Jiménez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. Am J Infect Control. 2014;42(10):1130-1132.doi:10.1016/j.ajic.2014.06.027
  7. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. Am J Infect Control. 2016;44(12):1526-1529. doi:10.1016/j.ajic.2016.04.236
  8. 2024 IQVIA CVC Market share data on file.
  9. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). Atlanta, GA: Centers for Disease Control and Prevention; 2017.
  10. Nickel B, Gorski LA, Kleidon TM, et al. Infusion therapy standards of practice. J Infus Nurs. 2024;47(suppl1):S1-S285.
  11. Compendium of strategies to prevent healthcare-associated infections in acute care hospitals. SHEA. Accessed January 29, 2024. https://shea-online.org/compendium-of-strategies-to-prevent-healthcare-associated-infections-in-acute-care-hospitals
  12. Preventing Catheter-Associated Bloodstream Infections (CABSI) in Adults.; 2025. Accessed June 23, 2025. https://apic.org/wp-content/uploads/2025/06/2025-CABSI-Implementation-Guide-004.pdf
  13. Mermel LA. What is the evidence for intraluminal colonization of hemodialysis catheters? Kidney Int. 2014;86(1):28-33. doi:10.1038/ki.2013.527
  14. Arrowg+ard Blue Plus™ Protection Clinical References. MC-004391. Available from Teleflex
  15. Rosenbauer KA, Herzer JA. Surface morphology and tensile force at breaking point or different kinds of intravenous catheters before and after usage. Scan Electron Microsc. 1981;(Pt 3):125-30.
  16. Arrow™ ErgoPack™ Complete Claims Matrix. MC-005776 Rev 1.
Rx only

Contraindication: Arrowg+ard Blue Plus™ Central Venous Catheters are contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.

Refer to package insert provided with the product for complete warnings, indications, contraindications, precautions, potential complications and instructions for use.

BIOPATCH is a registered trademark of Johnson & Johnson. ChloraPrep is a registered trademark of Becton, Dickinson and Company. 3M and Tegaderm are registered trademarks of 3M.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, Blue FlexTip, ErgoPack, and GlideWheel are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. MC-011049

Want to learn more?
We want to connect with you.
Request More Information